Advisors Asset Management Inc. raised its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 26.3% during the second quarter, Holdings Channel reports. The fund owned 54,565 shares of the medical equipment provider’s stock after buying an additional 11,354 shares during the period. Advisors Asset Management Inc.’s holdings in Zimmer Biomet Holdings were worth $7,006,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of ZBH. Enterprise Financial Services Corp boosted its stake in shares of Zimmer Biomet Holdings by 0.3% in the second quarter. Enterprise Financial Services Corp now owns 2,646 shares of the medical equipment provider’s stock valued at $340,000 after buying an additional 9 shares in the last quarter. Alpha Windward LLC boosted its stake in shares of Zimmer Biomet Holdings by 1.1% in the first quarter. Alpha Windward LLC now owns 1,651 shares of the medical equipment provider’s stock valued at $202,000 after buying an additional 18 shares in the last quarter. Sandy Spring Bank boosted its stake in shares of Zimmer Biomet Holdings by 1.7% in the first quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock valued at $149,000 after buying an additional 20 shares in the last quarter. Parkside Financial Bank & Trust boosted its stake in shares of Zimmer Biomet Holdings by 2.7% in the first quarter. Parkside Financial Bank & Trust now owns 839 shares of the medical equipment provider’s stock valued at $102,000 after buying an additional 22 shares in the last quarter. Finally, Cleararc Capital Inc. boosted its stake in shares of Zimmer Biomet Holdings by 0.5% in the first quarter. Cleararc Capital Inc. now owns 4,897 shares of the medical equipment provider’s stock valued at $598,000 after buying an additional 25 shares in the last quarter. 82.84% of the stock is currently owned by institutional investors and hedge funds.

Zimmer Biomet Holdings, Inc. (ZBH) opened at 112.97 on Wednesday. Zimmer Biomet Holdings, Inc. has a one year low of $95.63 and a one year high of $133.49. The company has a 50-day moving average of $124.00 and a 200 day moving average of $121.30. The firm has a market capitalization of $22.84 billion, a price-to-earnings ratio of 32.18 and a beta of 1.20.

Zimmer Biomet Holdings (NYSE:ZBH) last posted its earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.10 by $0.02. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The business had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.95 billion. During the same period in the previous year, the firm earned $2.02 earnings per share. The company’s revenue was up 1.1% compared to the same quarter last year. On average, analysts anticipate that Zimmer Biomet Holdings, Inc. will post $8.24 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 22nd will be issued a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date of this dividend is Thursday, September 21st. Zimmer Biomet Holdings’s payout ratio is 27.59%.

TRADEMARK VIOLATION WARNING: This piece of content was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/16/advisors-asset-management-inc-has-7-01-million-position-in-zimmer-biomet-holdings-inc-zbh.html.

ZBH has been the topic of several research analyst reports. Needham & Company LLC upped their price objective on shares of Zimmer Biomet Holdings from $151.00 to $153.00 and gave the stock a “strong-buy” rating in a research note on Friday, April 28th. Oppenheimer Holdings, Inc. set a $132.00 price objective on shares of Zimmer Biomet Holdings and gave the stock a “buy” rating in a research note on Friday, April 28th. Goldman Sachs Group, Inc. (The) initiated coverage on shares of Zimmer Biomet Holdings in a research note on Tuesday, May 16th. They set a “sell” rating and a $92.00 price objective on the stock. Wells Fargo & Company cut shares of Zimmer Biomet Holdings from an “outperform” rating to a “market perform” rating in a research note on Friday, April 28th. Finally, Zacks Investment Research cut shares of Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a research note on Tuesday, July 4th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $136.90.

In other Zimmer Biomet Holdings news, insider Sang Yi sold 17,731 shares of the business’s stock in a transaction that occurred on Monday, June 12th. The shares were sold at an average price of $124.56, for a total transaction of $2,208,573.36. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Tony W. Collins sold 16,986 shares of the business’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $121.74, for a total transaction of $2,067,875.64. The disclosure for this sale can be found here. Insiders own 1.07% of the company’s stock.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Stock Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related stocks with our FREE daily email newsletter.